Updated Guidance for the Children’s Yale‑Brown Obsessive‑Compulsive Scale (CY‑BOCS‑II)
Structural Modifications
- The CY‑BOCS‑II removes one item from the original scale and adds a new item (item 4), enabling clinicians to generate both original CY‑BOCS and CY‑BOCS‑II scores in a single administration through back‑coding of the ratings【1】.
Clinical Administration
- Clinicians must apply professional judgment when using the content‑independent CY‑BOCS‑II to correctly categorize obsessive‑compulsive symptoms and to differentiate them from other intrusive‑thought disorders【1】.
- The scale quantifies severity by assessing (a) the amount of time spent on obsessions/compulsions, (b) the level of distress experienced, and (c) the degree of functional interference in daily activities【2】.
- Failure to evaluate family accommodation (e.g., reassurance or participation in rituals) can bias interference ratings and lead to underestimation of symptom severity【1】.
- Extensive avoidance of triggering situations may also cause underestimation of true severity because patients spend less observable time on active obsessions/compulsions despite significant functional impairment【2】.
Severity Classification
- The CY‑BOCS‑II retains the original severity bands: 0‑7 = subclinical, 8‑15 = mild, 16‑23 = moderate, 24‑31 = severe, with a total possible score of 0‑40【2】.
- A total score of ≥ 28 identifies severe, treatment‑refractory OCD in youth aged 8‑18 years, indicating the need for intensified or alternative therapeutic strategies【2】.
Treatment Monitoring
- A clinically meaningful response is defined as a ≥ 35 % reduction from baseline CY‑BOCS‑II (or original CY‑BOCS) scores【1】.
- The CY‑BOCS‑II is sensitive to change in telepsychiatry interventions; youth receiving internet‑based therapy demonstrated significant improvement on CY‑BOCS measures【3】.
Treatment Recommendations for Pediatric OCD Based on CY‑BOCS‑II Scores
Moderate OCD (CY‑BOCS‑II score 16–23)
- In youth with moderate OCD, clinicians should start cognitive‑behavioral therapy with exposure and response prevention (CBT/ERP) and consider adding a selective serotonin reuptake inhibitor (SSRI) if the CBT response is insufficient after 8–12 weeks of treatment. 4, 5, 6
Severe OCD (CY‑BOCS‑II score 24–31)
- For severe OCD, a combined approach of CBT/ERP and SSRI pharmacotherapy should be initiated concurrently to maximize symptom reduction. 4, 5, 6